Horizon Investment Services, LLC Vertex Pharmaceuticals Inc Transaction History

Horizon Investment Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$392.81 - $485.53 $34,960 - $43,212	-89 Reduced 1.53%	5,712 $2.68 Million
Q1 2024 May 07, 2024	SELL	$407.69 - $446.08 $218,114 - $238,652	-535 Reduced 8.44%	5,801 $2.42 Million
Q4 2023 Feb 12, 2024	BUY	$343.0 - $410.68 $237,356 - $284,190	692 Added 12.26%	6,336 $2.58 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $19,614 - $21,022	-58 Reduced 1.02%	5,644 $1.96 Million
Q2 2023 Aug 07, 2023	SELL	$314.42 - $351.91 $9,432 - $10,557	-30 Reduced 0.52%	5,702 $2.01 Million
Q1 2023 May 08, 2023	BUY	$283.23 - $323.1 $116,407 - $132,794	411 Added 7.72%	5,732 $1.81 Million
Q4 2022 Feb 07, 2023	BUY	$285.76 - $321.48 $1.52 Million - $1.71 Million	5,321 New	5,321 $1.54 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Horizon Investment Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Horizon Investment Services, LLC with notifications on news.